Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05998785 · ClinicalTrials.gov registry record
Embody Insertional Achilles Tendinopathy
A clinical trial, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- 8
- Enrollment target
NCT05998785 is a clinical trial that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 8 participants.
The verdict
NCT05998785 was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the long-term effects on ankle/Achilles tendon pain after repair of insertional Achilles tendinopathy (IAT) augmented with TAPESTRY Biointegrative Implant.
Interventions
- DEVICE TAPESTRY Biointegrative Implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2022-08-02 |
| Est. Completion | 2024-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05998785
The ClinicalTrials.gov registry entry for NCT05998785 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TAPESTRY Biointegrative Implant is the first listed.
NCT05998785 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05998785 about?
NCT05998785 is a clinical study titled "Embody Insertional Achilles Tendinopathy". The primary objective of this study is to evaluate the long-term effects on ankle/Achilles tendon pain after repair of insertional Achilles tendinopathy (IAT) augmented with TAPESTRY Biointegrative Implant.
What is the current status of trial NCT05998785?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2022-08-02. Estimated completion is 2024-08-01.
What interventions are being tested in trial NCT05998785?
The interventions under investigation include: TAPESTRY Biointegrative Implant (DEVICE).
Who is sponsoring clinical trial NCT05998785?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.